United States · Series A startup

Who invested in Immune-Onc Therapy

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 27 Oct 2026

$7.0Mraised across 1 round since 2016, from 1 source

Latest round
Series A, $7.0MSept 2016
Investors
2
See who backed them

The rounds

  1. Sept 2016
    Series A$7.0M
    • CLI Ventures et al
    • Fame Mount Limited

    Reported by FinSMEs

Everyone who backed them

CLI Ventures et alno record of our own yet1round
Fame Mount Limitedno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Immune-Onc Therapy

Who invested in Immune-Onc Therapy?

Immune-Onc Therapy's investors include CLI Ventures et al and Fame Mount Limited.

How much has Immune-Onc Therapy raised?

Immune-Onc Therapy has raised $7.0M across 1 round since 2016.

When did Immune-Onc Therapy last raise?

Immune-Onc Therapy's most recent round was a Series A of $7.0M in Sept 2016.

What was Immune-Onc Therapy's biggest round?

Its most recent round, $7.0M in Sept 2016, is also its largest on record.

Who backed Immune-Onc Therapy first?

Immune-Onc Therapy's first round on record, in Sept 2016, was backed by CLI Ventures et al and Fame Mount Limited.

What stage is Immune-Onc Therapy at?

Immune-Onc Therapy's latest named round is a Series A, in Sept 2016.

Where is Immune-Onc Therapy based?

Immune-Onc Therapy is based in the United States.

Companies like Immune-Onc Therapy

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.